Cao Bin, Diamond Michael S, Mysorekar Indira U
1 Department of Obstetrics and Gynecology, Washington University School of Medicine , St. Louis, Missouri.
2 Department of Medicine, Washington University School of Medicine , St. Louis, Missouri.
J Interferon Cytokine Res. 2017 Jul;37(7):287-294. doi: 10.1089/jir.2017.0011. Epub 2017 Apr 12.
The emerging mosquito-borne virus, Zika virus (ZIKV), has been causally associated with adverse pregnancy and neonatal outcomes, including miscarriage, microcephaly, serious brain abnormalities, and other birth defects indicative of a congenital ZIKV syndrome. In this review, we highlight work from human and animal studies on routes of infection in pregnancy that lead to adverse fetal and neonatal outcomes. A number of innate and adaptive immune mechanisms and signaling molecules that may have key roles in ZIKV infection pathogenesis are discussed along with putative viral entry pathways. A more granular understanding of pathogenesis of ZIKV infection during pregnancy is critical for developing therapeutics and vaccines and mounting a global public health response to limit ZIKV infections. We also report on new therapeutic interventions that have shown success in preclinical studies.
新出现的蚊媒病毒寨卡病毒(ZIKV)已被证实与不良妊娠及新生儿结局存在因果关系,这些结局包括流产、小头畸形、严重脑异常以及其他表明先天性寨卡病毒综合征的出生缺陷。在本综述中,我们重点介绍了来自人类和动物研究的关于孕期感染途径导致不良胎儿和新生儿结局的工作。我们还讨论了一些可能在寨卡病毒感染发病机制中起关键作用的先天性和适应性免疫机制及信号分子,以及假定的病毒进入途径。更深入地了解孕期寨卡病毒感染的发病机制对于开发治疗方法和疫苗以及开展全球公共卫生应对措施以限制寨卡病毒感染至关重要。我们还报告了在临床前研究中已显示出成功的新治疗干预措施。